The 18 analysts offering 12-month price forecasts for Elevance Health Inc have a median target of 580.00, with a high estimate of 620.00 and a low estimate of 523.00. The median estimate represents a +21.41% increase from the last price of 477.72.
The current consensus among 20 polled investment analysts is to Buy stock in Elevance Health Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $9.33
Reporting Date Apr 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.